• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lorad scores deal with U.S. Surgical

Article

Mammography vendor Lorad of Danbury, CT, has signed an exclusivemultiyear agreement with breast biopsy instrument supplier U.S.Surgical that could be worth up to $10 million to Lorad in thefirst year of the contract. Under the terms of the deal,

Mammography vendor Lorad of Danbury, CT, has signed an exclusivemultiyear agreement with breast biopsy instrument supplier U.S.Surgical that could be worth up to $10 million to Lorad in thefirst year of the contract. Under the terms of the deal, Loradwill supply stereotactic equipment such as its StereoGuide coreneedle biopsy system to U.S. Surgical for use with that company'sAdvanced Breast Biopsy Instrument (ABBI) system. ABBI employsa one-step procedure to both place a wire marker in the breastand remove a tissue specimen for biopsy.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.